Kezar Life Sciences CEO and Key Executive Team

• Franklin Berger

  Director
• John Fowler

  Chief Executive Officer, Co-Founder and Director
• Graham Cooper

  Director
• Noreen Roth Henig

  Chief Medical Officer
• Marc Belsky

  Chief Financial Officer
• Elizabeth Garner

  Director
• Nick Mordwinkin

  Chief Business Officer
• Christopher Kirk

  President, Chief Scientific Officer, Co-Founder, Director
• Mark Schiller

  Senior Vice President, Legal Affairs
• Michael Wolfe

  Vice President, Finance and Business Operations
• Michael Kauffman

  Director
• Gitanjali Jain

  VP, Investor Relations & External Affairs
• Rui Li

  VP, Clinical Development, Oncology
• Micki Klearman

  Director
• Courtney Wallace

  DIrector
• Jinhai Wang

  VP, Drug Metabolism & Pharmacokinetics
• Michelle Greenman

  VP, Global Regulatory Affairs
• Neel K. Anand

  VP, Medicinal Chemistry & Head of Drug Discovery
• Jyotin J. Vyas

  VP, Program & Alliance Management
• Tony Muchamuel

  VP, Pharmacology & Toxicology
• R. Andrea Fan

  VP, Biology
• Kieron Wesson

  VP, Pharmaceutical Development & CMC
• Steven Y. Hua

  VP, Biometrics
• Li Long

  VP, Clinical Development, Immunology
• Rafael Sarabia

  VP, Pharmaceutical Development
• Pattie Chiang

  Vice President, Corporate Controller

Source: kezarlifesciences.com, kezarlifesciences.com, kezarlifesciences.com, kezarlifesciences.com, kezarlifesciences.com, kezarlifesciences.com, kezarlifesciences.com, kezarlifesciences.com